Contrad Swiss—a dynamic Swiss-based pharmaceutical corporation revolutionizing the regenerative medicine landscape. Our portfolio, comprising medical devices and cosmetic products manufactured in EU and Swiss facilities, is backed by clinical evidence and ongoing studies proving both efficacy and safety. All our solutions are topical, taking peptides as active ingredients to the next level. ACTV8PRO™ and ACTV8SKN™ are regenerative, non-invasive aesthetic product lines powered by SIGMOLECS™ Technology. ACTV8PRO™ is designed for in-clinic use, offering short-term recovery solutions that reduce downtime, boost skin regeneration, and enhance treatment results within the first week. ACTV8SKN™ supports treatments like lasers, microneedling, and fillers, improving hydration, elasticity, and recovery for long-term benefits. Both integrate seamlessly into pre- and post-procedure protocols for comprehensive care.